What is the incidence and prevalence of anti‑N‑methyl‑D‑aspartate receptor (NMDAR) encephalitis, and how often does it initially present with predominant psychiatric symptoms?

Anti-NMDAR Encephalitis Prevalence and Psychiatric Presentation

Anti-NMDAR encephalitis is now recognized as a common form of autoimmune encephalitis, with approximately 77% of patients presenting initially with psychiatric symptoms, making it a critical diagnostic consideration for any patient with acute-onset psychosis, especially when accompanied by agitation or catatonia 1.

Epidemiology and Prevalence

Anti-NMDAR encephalitis has evolved from being considered rare to being recognized as one of the most common autoimmune encephalitides since its formal description in 2007 2. The condition predominantly affects:

• Children and young women (particularly those under 40 years)
• Female predominance, especially in young adults where up to 50% may have an ovarian teratoma 3
• Teratomas are much less common in children 3

In psychiatric populations specifically, the prevalence data shows:

• Among patients with schizophrenia and related psychoses, 7.98% test positive for anti-NMDAR antibodies (any subclass), but only 1.46% are positive for the pathogenic IgG subclass 4
• In first-episode psychosis populations, the prevalence of definite NMDAR encephalitis meeting consensus criteria is less than 1% 5
• Among treatment-resistant schizophrenia patients on clozapine, approximately 1% are seropositive but do not necessarily meet criteria for encephalitis 5

Psychiatric Presentation Patterns

Initial Presentation

The psychiatric presentation is remarkably common and often misleading:

• 77% of all anti-NMDAR encephalitis patients present initially with psychiatric symptoms 1
• 70% are initially admitted to psychiatric wards rather than neurology services 6
• 37.5% present with purely psychiatric symptoms without obvious neurological signs at onset 6

Specific Psychiatric Symptoms

The most common psychiatric manifestations include:

Agitation (59% overall):

• Even more prominent in children (66%) 1
• Often severe and treatment-refractory

Psychotic symptoms (54%):

• Visual hallucinations (64%) and auditory hallucinations (59%) 1
• Persecutory delusions (73%) when delusions are characterized 1
• Disorganized behavior is particularly prominent 1

Catatonia:

• Present in 42% of adults and 35% of children 1
• This is a critical red flag that should prompt consideration of organic causes

Clinical Evolution and Red Flags

The key diagnostic challenge is that psychiatric symptoms typically precede obvious neurological features by days to weeks 3. The typical progression follows this pattern:

1. Days 1-7: Acute anxiety, behavioral changes, psychosis, mood lability
2. Days 7-14: Seizures or neuropsychological deficits become apparent, defining an organic condition
3. Weeks 2-4: Reduced consciousness, movement disorders (dyskinesias, choreoathetosis), hypoventilation, and autonomic instability often requiring ICU admission 3

Critical warning signs that should trigger consideration of anti-NMDAR encephalitis:

• Neuroleptic intolerance: 33% of patients exposed to antipsychotics develop adverse reactions, with 22% developing neuroleptic malignant syndrome 1, 6
• Rapid deterioration on antipsychotic treatment, especially at low doses 7, 6
• Young age (children, adolescents, young adults) with new-onset psychosis
• Presence of subtle neurological signs (orofacial dyskinesias, tongue movements, ataxia) 8, 7
• Catatonic features
• Seizures accompanying psychiatric symptoms

Diagnostic Considerations

Important caveats for clinicians:

• MRI is frequently non-informative in anti-NMDAR encephalitis 3
• CSF pleocytosis is very common at onset (unlike typical psychiatric disorders) 3
• The mean time to diagnosis is 26.7 days, often delayed because patients are initially managed in psychiatric settings 6
• EEG can help differentiate from primary psychiatric disorders when it shows focal abnormalities, though it can be normal 9

The presence of anti-NMDAR antibodies alone does not establish the diagnosis - consensus criteria require compatible clinical features. Serum antibody testing has limited specificity; CSF testing is more reliable 5, 8.

Clinical Implications

Given that the majority of patients present psychiatrically and 70% are initially admitted to psychiatric wards, psychiatrists must maintain high clinical suspicion for this treatable condition. The development of neuroleptic intolerance or rapid clinical deterioration should immediately prompt neurological consultation and antibody testing 6.

Antipsychotics should be used with extreme caution in suspected cases, as one-third develop adverse reactions that can complicate the clinical picture and delay diagnosis 1, 6.

Relapses occur in 20-25% of non-paraneoplastic patients, sometimes separated by months or years 3.